4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)-1-triphenylmethylimidazole | 183281-27-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)-1-triphenylmethylimidazole
• 英文别名: 4-(2-Methyl-1,3-dihydro-2-benzosilol-2-yl)-1-tritylimidazole
• CAS: 183281-27-8
• 化学式: C₃₁H₂₈N₂Si
• 分子量: 456.662
• InChiKey: KMXMULKQNBQAMA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.89
• 重原子数：
  34
• 可旋转键数：
  5
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)-1-triphenylmethylimidazole 在 盐酸 作用下， 反应 0.5h， 生成 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole
  参考文献：
  名称：

  Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole

  摘要：

  4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available alpha(2)-adrenergic receptor antagonist atipamezole 1, were prepared and their pharmacological properties were evaluated. The results show that 2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of 2a were comparable to those of 1.

  DOI：

  10.1016/0223-5234(96)85882-x
• 作为产物：
  描述：

  2,2-Dimethoxy-2-silaindan 在 乙基溴化镁 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 5.0h， 生成 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)-1-triphenylmethylimidazole
  参考文献：
  名称：

  Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole

  摘要：

  4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available alpha(2)-adrenergic receptor antagonist atipamezole 1, were prepared and their pharmacological properties were evaluated. The results show that 2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of 2a were comparable to those of 1.

  DOI：

  10.1016/0223-5234(96)85882-x